Live Analyst Rating Changes 1525 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Erin Wright
MS
Erin Wright
Wall Street Analyst
★★★★☆
#442
on 13Foresight · ranked by our own returns
52%
Success Rate
+7.0%
Average Return
25 of 48 calls profitable · +5.6% vs benchmark
📈 Across the calls we could measure, roughly 52% of Erin Wright's ratings turned a profit when each position was held for 1 year — averaging +7.0% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

72 Buy 52 Hold 10 Sell
Erin's Stock Coverage 41 ratings · 2026-06-21
Company Date Position Consensus Price Target 1-Yr Return
DGX
Quest Diagnostics
Jun 09, 2026 BUY Buy
-12.4% avg upside
33 analysts
$226.00
15.98% Upside
-3.3%
ELV
Elevance Health
Jun 04, 2026 HOLD Strong Buy
+10.9% avg upside
32 analysts
$404.00
4.03% Upside
-4.7%
CNC
Centene
Jun 04, 2026 HOLD Buy
+8.6% avg upside
28 analysts
$57.00
6.50% Downside
-3.3%
MOH
Molina Healthcare
Jun 04, 2026 HOLD Buy
+13.8% avg upside
25 analysts
$167.00
14.42% Downside
+3.9%
HUM
Humana
Jun 04, 2026 SELL Buy
-11.2% avg upside
34 analysts
$249.00
30.96% Downside
-3.5%
CVS
CVS Health
Jun 04, 2026 BUY Strong Buy
+3.2% avg upside
38 analysts
$111.00
12.80% Upside
+3.7%
UNH
UnitedHealth
Jun 04, 2026 BUY Strong Buy
+2.3% avg upside
35 analysts
$453.00
12.94% Upside
+1.7%
BTSG
BrightSpring Health Services, Inc.
Jun 02, 2026 BUY Strong Buy
-16.3% avg upside
18 analysts
$71.00
7.07% Upside
+8.6%
ELAN
Elanco Animal Health
Jun 02, 2026 HOLD Strong Buy
+24.1% avg upside
18 analysts
$23.00
5.07% Downside
+2.5%
ALGN
Align Tech
May 28, 2026 HOLD Strong Buy
+56.4% avg upside
21 analysts
$188.00
3.28% Upside
+0.2%
CI
Cigna
May 21, 2026 BUY Strong Buy
+24.2% avg upside
29 analysts
$361.00
29.21% Upside
+1.7%
ZTS
Zoetis
May 15, 2026 BUY Buy
+71.4% avg upside
22 analysts
$115.00
46.10% Upside
+4.1%
MCK
McKesson
May 14, 2026 BUY Strong Buy
-2.2% avg upside
27 analysts
$966.00
28.78% Upside
+3.8%
COR
Cencora
May 08, 2026 BUY Buy
+14.6% avg upside
43 analysts
$342.00
25.76% Upside
+6.4%
MDLN
Medline
May 07, 2026 BUY Strong Buy
+42.9% avg upside
26 analysts
$52.00
44.73% Upside
-14.1%
XRAY
DENTSPLY SIRONA
May 06, 2026 HOLD Buy
+170.6% avg upside
25 analysts
$12.00
16.09% Upside
-5.1%
OPCH
Option Care Health
May 06, 2026 BUY Strong Buy
+34.7% avg upside
20 analysts
$28.00
27.29% Upside
+6.2%
HSIC
Henry Schein
May 05, 2026 SELL Buy
+7.4% avg upside
25 analysts
$64.00
19.82% Downside
-7.5%
IDXX
Idexx Laboratories
May 05, 2026 BUY Strong Buy
+29.2% avg upside
17 analysts
$805.00
43.24% Upside
-0.2%
CAH
Cardinal Health
May 05, 2026 BUY Strong Buy
-12.7% avg upside
29 analysts
$255.00
15.02% Upside
+14.9%
NVST
Envista Holdings
Apr 24, 2026 HOLD Buy
+12.8% avg upside
19 analysts
$21.00
18.93% Downside
-13.4%
LH
Labcorp Holdings
Feb 18, 2026 BUY Strong Buy
+1.8% avg upside
36 analysts
$308.00
20.40% Upside
-7.8%
PAHC
Phibro Animal Health
Feb 06, 2026 HOLD Hold
+17.0% avg upside
10 analysts
$49.00
53.91% Upside
-38.8%
PETS
Petmed Express
Jul 29, 2025 SELL Sell
+700.0% avg upside
6 analysts
$3.00
71.53% Upside
+30.8%
SDCCQ
SmileDirectClub
Aug 10, 2023 HOLD Hold
+513999900.0% avg upside
10 analysts
$0.90
89999899.93% Upside
·
SONX
Sonendo
May 10, 2023 HOLD Buy
+1875.0% avg upside
5 analysts
$5.00
733.33% Upside
·
RPD
Rapid7
Feb 09, 2023 HOLD Hold
+250.2% avg upside
29 analysts
$48.00
613.13% Upside
+20.5%
LNTH
Lantheus
Jul 28, 2021 HOLD Strong Buy
-27.9% avg upside
20 analysts
$26.00
74.93% Downside
+180.5%
CRL
Charles River Labs
Jul 20, 2021 HOLD Strong Buy
+11.9% avg upside
34 analysts
$385.00
108.13% Upside
-40.3%
MEDP
Medpace Holdings
Jul 20, 2021 BUY Buy
-12.1% avg upside
16 analysts
$205.00
55.37% Downside
-14.3%
IQV
IQVIA Holdings
Jul 20, 2021 BUY Strong Buy
+34.5% avg upside
38 analysts
$265.00
57.91% Upside
-10.7%
ICLR
Icon
Jul 20, 2021 BUY Strong Buy
+23.8% avg upside
25 analysts
$250.00
71.25% Upside
-0.5%
DHR
Danaher
Jun 18, 2021 BUY Strong Buy
+21.9% avg upside
45 analysts
$288.00
62.57% Upside
-6.9%
CHWY
Chewy
Jun 09, 2021 BUY Strong Buy
+122.7% avg upside
41 analysts
$121.00
564.45% Upside
-61.8%
MRVI
Maravai Lifesciences Holdings
May 11, 2021 BUY Strong Buy
+174.4% avg upside
17 analysts
$44.00
746.21% Upside
-15.3%
FLGT
Fulgent Genetics
Mar 16, 2021 SELL Hold
+142.6% avg upside
7 analysts
$55.00
205.60% Upside
+45.4%
CERT
Certara
Mar 05, 2021 HOLD Buy
+133.5% avg upside
21 analysts
$36.00
549.88% Upside
-25.0%
TMO
Thermo Fisher
Jan 12, 2021 BUY Strong Buy
+26.8% avg upside
38 analysts
$580.00
24.93% Upside
+25.6%
AVTR
Avantor
Jul 29, 2020 BUY Buy
+49.6% avg upside
26 analysts
$25.00
161.00% Upside
+89.6%
ACH
Accendra Health
May 10, 2018 SELL Sell
+439.4% avg upside
17 analysts
$13.00
302.45% Upside
+73.1%
STE
Steris
Mar 15, 2013 BUY Strong Buy
+21.8% avg upside
10 analysts
$43.00
78.72% Downside
+18.1%
🔒 36 more ratings — with price targets, crowd consensus and our measured returns.
Free account unlocks every analyst's full coverage table.
Erin Wright — Frequently Asked Questions
How accurate are Erin Wright's stock ratings?
Based on the calls 13Foresight could measure, about 52% of Erin's ratings were profitable over a one-year hold, with an average return of +7.0% per rating, or +5.6% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Erin ranked on 13Foresight?
Erin Wright is currently ranked #442 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Erin cover?
Erin most recently has ratings on DGX, ELV, CNC, MOH, HUM, CVS, UNH, BTSG, ELAN, ALGN, CI, ZTS and 29 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.